{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T21:01:28Z","timestamp":1764277288396,"version":"3.35.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.transci.2024.104045","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:28:12Z","timestamp":1733876892000},"page":"104045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of febrile neutropenia episodes and blood product transfusions in children with acute leukemia"],"prefix":"10.1016","volume":"64","author":[{"given":"\u0130rem Ceren","family":"Erba\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lknur","family":"Akansu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem T\u00fcfek\u00e7i","family":"G\u00fcrocak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eebnem","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur\u015fen","family":"Belet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hale","family":"\u00d6ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transci.2024.104045_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jen.2013.07.021","article-title":"Management of febrile neutropenia in a patient with acute leukemia","volume":"40","author":"Bryant","year":"2014","journal-title":"J Emerg Nurs"},{"key":"10.1016\/j.transci.2024.104045_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijh.ijh_12_18","article-title":"A one year anticipated blood transfusion requirements among patients with acute leukemia undergoing chemotherapy in the National Center of Hematology in Baghdad","volume":"8","author":"Alwan","year":"2019","journal-title":"Iraqi J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2024.104045_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/cc2847","article-title":"Infectious and immunologic consequences of blood transfusion","volume":"8","author":"Dellinger","year":"2004","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.transci.2024.104045_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4103\/0019-5049.144675","article-title":"Blood transfusion practices in cancer surgery","volume":"58","author":"Cata","year":"2014","journal-title":"Indian J Anaesth"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib5","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.009","article-title":"Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment","volume":"12","author":"Hansen","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.transci.2024.104045_bib6","article-title":"Diagnostics and therapy of paediatric patients with febrile neutropenia","volume":"2","author":"Koenig","year":"2023","journal-title":"EJC Paediatr Oncol"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOH.0b013e32834da951","article-title":"Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia","volume":"19","author":"Dubos","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2024.104045_bib8","article-title":"Infections in children and adolescents with Acute Leukemia","volume":"3","author":"Carlesse","year":"2024","journal-title":"EJC Paediatr Oncol"},{"issue":"3","key":"10.1016\/j.transci.2024.104045_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4274\/tjh.galenos.2023.2023.0185","article-title":"Etiology and factors affecting severe complications and mortality of febrile neutropenia in children with acute leukemia","volume":"40","author":"Erba\u015f","year":"2023","journal-title":"Turk J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2278-330X.202565","article-title":"Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia","volume":"6","author":"Krishnamani","year":"2017","journal-title":"South Asian J Cancer"},{"issue":"3","key":"10.1016\/j.transci.2024.104045_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MPH.0000000000002530","article-title":"Blood transfusion is associated with adverse outcomes in pediatric solid tumor oncology patients following tumor resection","volume":"45","author":"Acker","year":"2023","journal-title":"J Pedia Hematol Oncol"},{"key":"10.1016\/j.transci.2024.104045_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","article-title":"Infectious diseases society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2024.104045_bib13","article-title":"Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012","volume":"13","author":"von Allmen","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.transci.2024.104045_bib14","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI Document M100-S21. Wayne (PA), Clinical and Laboratory Standards Institute, 2011."},{"key":"10.1016\/j.transci.2024.104045_bib15","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haemato poietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2024.104045_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","author":"Slichter","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.transci.2024.104045_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/asheducation-2008.1.198","article-title":"New strat- egies for the optimal use of platelet transfusions","author":"Blajchman","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.transci.2024.104045_bib18","unstructured":"Walsh T.J. Infectious complications in pediatric cancer patients. In: Pizzo P.A., Poplack D.G., editors. Principles and practice of pediatric oncology. 5th ed; Philadelphia: Williams and Wilkins. 2006, p. 1269\u20131329.."},{"issue":"2","key":"10.1016\/j.transci.2024.104045_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12098-012-0901-y","article-title":"Febrile neutropenia: outline of management","volume":"80","author":"Oberoi","year":"2013","journal-title":"Indian J Pedia"},{"issue":"6","key":"10.1016\/j.transci.2024.104045_bib20","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.athoracsur.2012.11.078","article-title":"Blood transfusion and infection after cardiac surgery","volume":"95","author":"Horvath","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.transci.2024.104045_bib21","doi-asserted-by":"crossref","unstructured":"McCullough J. Transfusion-Transmitted Diseases. In: McCullough J. Editor. Transfusion Medicine. 5th ed; Hoboken, NJ, USA. John Wiley & Sons Ltd. 2021, p. 422-452. https:\/\/doi.org\/10.1002\/9781119599586.ch17..","DOI":"10.1002\/9781119599586.ch17"},{"issue":"2","key":"10.1016\/j.transci.2024.104045_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/trf.15644","article-title":"A suspected septic transfusion reaction associated with posttransfusion contamination of a platelet pool by vancomycin-resistant Enterococcus faecium","volume":"60","author":"Drews","year":"2020","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2024.104045_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.hoc.2019.05.002","article-title":"Existing and emerging blood-borne pathogens: impact on the safety of blood transfusion for the hematology\/oncology patient","volume":"33","author":"Wagner","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.transci.2024.104045_bib24","first-page":"104","article-title":"Infection after injury: association with blood transfusion","volume":"58","author":"Rosemurgy","year":"1992","journal-title":"Am Surg"},{"key":"10.1016\/j.transci.2024.104045_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.1984.01390130010002","article-title":"Risk of infection following laparotomy for penetrating abdominal injury","volume":"119","author":"Dellinger","year":"1984","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.transci.2024.104045_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1017\/S0195941700079959","article-title":"Predictors of nosocomial bloodstream infections among critically ill adult trauma patients","volume":"25","author":"El-Masri","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.transci.2024.104045_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0020-1383(00)00103-0","article-title":"Early risk factors for sepsis in patients with severe blunt trauma","volume":"32","author":"Flores","year":"2001","journal-title":"Injury"},{"issue":"5","key":"10.1016\/j.transci.2024.104045_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.TA.0000022460.21283.53","article-title":"Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta- analysis","volume":"54","author":"Hill","year":"2003","journal-title":"Anal J Trauma"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13054-018-2212-9","article-title":"Bacterial contamination of platelets for transfusion: strategies for prevention","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13054-016-1593-x","article-title":"Is platelet transfusion associated with hospital-acquired infections in critically ill patients?","volume":"21","author":"Aubron","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2024.104045_bib31","first-page":"197","article-title":"Blood transfusion-induced immunomodulation","volume":"82","author":"Landers","year":"1996","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.transci.2024.104045_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/CCM.0000000000003192","article-title":"Pediatric acute lung injury and sepsis investigators (PALISI) network, pediatric critical care blood research network (BloodNet), and the P3T investigators. Platelet transfusion practices in critically Ill children","volume":"46","author":"Nellis","year":"2018","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.transci.2024.104045_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2019.05.011","article-title":"Transfusion management in pediatric oncology patients","volume":"33","author":"Nellis","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.transci.2024.104045_bib34","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/PCC.0000000000002857","article-title":"Plasma and platelet transfusion strategies in critically ill children with malignancy, acute liver failure and\/or liver transplantation, or sepsis: from the transfusion and anemia expertise initiative-control\/avoidance of bleeding","volume":"23","author":"Lieberman","year":"2022","journal-title":"Pedia Crit Care Med"},{"issue":"9850","key":"10.1016\/j.transci.2024.104045_bib35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.transci.2024.104045_bib36","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.transci.2024.104045_bib37","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.transci.2024.104045_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000\/L versus 20,000\/microL trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.104045_bib39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000\/microL versus 20,000\/microL","volume":"15","author":"Heckman","year":"1997","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.transci.2024.104045_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104045_bib41","unstructured":"National Blood Authority. Patient Blood Management Guidelines: Module 6- Neonatal and Paediatrics, \u3008https:\/\/www.blood.gov.au\/pbm-module-6\u3009. 2021 [accessed 22 March 2021]."},{"key":"10.1016\/j.transci.2024.104045_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2110-5820-2-42","article-title":"Management of thrombocytopenia in the ICU (pregnancy excluded)","volume":"2","author":"Van der Linden","year":"2012","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1016\/j.transci.2024.104045_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102825","article-title":"Restrictive versus liberal transfusion strategies in patients with malignant neoplasm a meta-analysis of randomized controlled trials","volume":"59","author":"Yang","year":"2020","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022400226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022400226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:48:25Z","timestamp":1738572505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022400226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S147305022400226X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.104045","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of febrile neutropenia episodes and blood product transfusions in children with acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.104045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104045"}}